Perfusion Bioreactor Capillary Network for In Vivo-Like 3D Cell Culture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional 2D cell-culture models fail to accurately mimic in vivo environmental conditions and cellular behaviors, leading to high attrition rates of drug candidates and unforeseen toxicity issues, as they lack critical ECM components and interactions present in 3D environments.
Innovation Solution
A perfusion-based 3D bioreactor system utilizing capillary tubes and micro 3D printing techniques to create a 3D cell culture environment that promotes high-density cell-to-cell and cell-to-ECM interactions, mimicking in vivo conditions through precise control of pore size and nutrient transport.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If 2D cell-culture models are used, then the culture process is simple and well-established, but the model fails to accurately mimic in vivo environmental conditions and cellular behaviors
Solution Approach 1:
The patent transitions from conventional 2D cell culture to 3D cell culture by fabricating three-dimensional extracellular matrix (ECM) structures using two-photon polymerization micro 3D printing. This dimensional change enables cells to experience spatial organization, cell-to-cell interactions, and ECM influences that closely mimic in vivo conditions, thereby improving the reliability of the model while maintaining a controlled fabrication process.
2Reliability
If 3D scaffolds with optimal pore size (100-400 μm) are created to improve cell nutrition and growth, then sub-20 μm resolution manufacturing is required, increasing manufacturing complexity
Solution Approach 1:
The patent replaces conventional mechanical 3D printing methods with two-photon polymerization micro 3D printing, which uses photopolymerization chemistry to achieve sub-20 μm resolution. This substitution of manufacturing mechanism enables precise control of pore sizes (100-400 μm) and complex 3D scaffold architectures that are difficult to achieve with traditional mechanical fabrication methods.
Solution Approach 2:
The patent utilizes adjustable parameters in two-photon polymerization including laser power, scanning speed, and polymerization conditions to precisely control pore size, shape, and distribution within the 3D scaffold. By changing these parameters, the system can consistently create pores within the optimal 100-400 μm range while maintaining sub-20 μm manufacturing precision.
3Reliability
If high cell density is achieved to model in vivo conditions, then nutrient transport becomes insufficient, limiting cell health and function
Solution Approach 1:
The patent employs 3D porous scaffolds with controlled pore sizes (100-400 μm) that facilitate nutrient diffusion and transport throughout the cell culture. The porous structure increases surface area and creates channels that allow metabolites to reach high-density cell populations, maintaining cell health and function while enabling in vivo-like cell densities.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The bioreactor system effectively models in vivo biological conditions, enhancing drug development by improving cell culture accuracy and reducing drug candidate attrition and toxicity issues.
Implementation Method 1
Capillary tubes extending into the cavity from a bottom surface of the bioreactor opposite the top surface
Implementation Method 2
perfusion-based 3D bioreactor for 3D cell cultures with a capillary system to promote 3D cell-to-cell and cell-to-ECM interactions as well as to promote transportation of metabolites and metabolic waste
Data Source
AI summary
A 3D perfusion bioreactor system and method for more accurate modeling of in vivo environmental conditions and cellular behaviors. In some embodiments, the bioreactor includes a cavity for containing culture media and cells. A plurality of capillary tubes cross the cavity. Artery capillary tubes may transport culture media received from an inlet of the bioreactor, across the cavity, and into a return compartment. Vein capillary tubes may transport culture media from the return compartment, across the cavity, and to an outlet of the bioreactor. Metabolites may diffuse from the capillary tubes into the cavity for cellular consumption, and metabolic waste may diffuse from the cavity into the capillary tubes for removal from the bioreactor. In some embodiments, culture media discharged from the outlet may be processed via a waste treatment device and returned to the inlet.